• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Binance Withdraws MiCA Application from Greece

chest

Binance has withdrawn its MiCA application from Greece after reports indicated it would be denied, seeking approval through another EU member nation.

user avatarZainab Kamara

Binance Faces $200 Million Lawsuit in the UK

chest

Binance and its founder Changpeng Zhao are facing a UK lawsuit seeking nearly $200 million for allegedly offering complex financial instruments without regulatory approval.

user avatarJacob Williams

Ripple Expands Global Compliance Efforts Ahead of US Clarity Act Debate

chest

Ripple is expanding its licensing to improve compliance for cross-border use cases ahead of the US Clarity Act debate.

user avatarAyman Ben Youssef

Major Token Unlocks Scheduled for SUI, ENA, and EIGEN

chest

This week, a significant event in the crypto market is set to unfold as SUI, ENA, and EIGEN prepare to unlock a total of 73 million tokens.

user avatarSon Min-ho

Gensyn Gains Visibility with Upbit Listing

chest

Gensyn has gained visibility after Upbit announced trading support for the decentralized AI GPU compute project, adding GEN pairs against Korean won, Bitcoin, and USDT.

user avatarTando Nkube

Chainlink Wallet Growth Approaches 900,000

chest

The number of nonempty Chainlink (LINK) wallet addresses has reached 892,800, driven by the expansion of CCIP integration.

user avatarKofi Adjeman

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.